Fluocinolone acetonide/triamcinolone
Related Articles
- Irreversible cataracts? B.D.G. // Cortlandt Forum;09/25/97, Vol. 10 Issue 9, p104
Answers a query on whether cataracts can be treated by nutrients, herbs, vitamins or minerals. Reversal of adult-onset cataracts; Absence of scientific scrutiny that certain agents can treat cataracts.
- Immune globulin. // Reactions Weekly;6/1/2013, Issue 1455, p20
The article describes the case of a male patient with cytomegalovirus (CMV) retinitis who developed aggravation of blurred vision while receiving immune globulin.
- Alemtuzumab/fludarabine. // Reactions Weekly;8/14/2010, Issue 1314, p8
The article describes the case of a 20-year-old man who developed cytomegalovirus (CMV) retinitis and ventriculoencephalitis after taking alemtuzumab and fludarabine.
- Bortezomib. // Reactions Weekly;May2015, Vol. 1549 Issue 1, p51
The article presents a case study of a 65-year-old man with cytomegalovirus retinitis and pulmonary tuberculosis after administration of the drug bortezomib.
- Triamcinolone. // Reactions Weekly;1/8/2011, Issue 1333, p36
The article describes the case of a 78-year-old woman who developed cytomegalovirus (CMV) retinitis after treatment with triamcinolone for macular oedema.
- Triamcinolone. // Reactions Weekly;1/8/2011, Issue 1333, p37
The article describes the case of a 30-year-old man who developed cytomegalovirus (CMV) retinitis after receiving triamcinolone for panuveitis.
- Dexamethasone/mercaptopurine/methotrexate. // Reactions Weekly;4/13/2013, Issue 1448, p12
The article presents a case study of a seven-year-old boy who had cytomegalovirus (CMV) retinitis and haemophagocytic lymphohistiocytosis (HLH) after being treated with mercaptopurine, methotrexate, and dexamethasone.
- Triamcinolone. // Reactions Weekly;1/14/2012, Issue 1384, p55
The article describes the case of an 87-year-old immunocompetent man who developed cytomegalovirus (CMV) retinitis following a subtenon injection of triamcinolone.
- Low CD4+ count increases risk for CMV retinitis in patients with HIV/AIDS. Kronemyer, Bob // Primary Care Optometry News;Jan2013, Vol. 18 Issue 1, p16
The article discusses the results of a study which showed that risk for cytomegalovirus (CMV) retinitis increases in patients with HIV/AIDS with low CD4+ T-cell count, referencing a research published in the "Current Opinion in Ophthalmology" journal.
- Phase II Results Released for AzaSite for Blenharitis. // Review of Ophthalmology;Apr2010, Vol. 17 Issue 4, p14
The article presents the results of two Phase II clinical trials of Azasite (azithromycin ophthalmic solution) for blepharitis treatment.